Table: Aska Pharmaceutical -2016/17 group results

ASKA Pharmaceutical Holdings

12/05/2017 07:00

May 12 (Reuters)-  
          Aska Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           48.53           43.22          50.00        25.00     
               (+12.3 pct)     (+0.7 pct)     (+3.0 pct)    (+2.8 pct)  
  Operating        1.79            1.28           2.00         1.40     
               (+39.7 pct)     (-9.9 pct)     (+11.5 pct)   (+5.1 pct)  
  Recurring        2.00            1.52           2.10         1.50     
               (+31.6 pct)     (-11.6 pct)    (+4.9 pct)    (+3.1 pct)  
  Net                                             1.80         1.30     
                                              (-38.9 pct)   (+2.0 pct)  
  Net              2.94          701 mln                                
              (+319.8 pct)     (-41.2 pct)                              
  EPS          105.39 yen       25.15 yen      64.39 yen    46.51 yen   
  Ann Div       14.00 yen       14.00 yen      14.00 yen                
  -Q2 Div       7.00 yen        7.00 yen       7.00 yen                 
  -Q4 Div       7.00 yen        7.00 yen       7.00 yen                 
   
  NOTE - Aska Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T 
  ((Tokyo Headline News Desk +813 6441 1812))